Sign in Subscribe
European Union

European Commission Approves IPCEI Tech4Cure: A €1.23 Billion Medical Devices Initiative

Strategic Insights

— 2 min read

The European Commission has approved the second health-related Important Project of Common European Interest (IPCEI) to support innovations in medical devices, specifically the introduction of novel digital and artificial intelligence (AI) features. This project, called IPCEI Tech4Cure, involves 10 companies, including 6 small and medium-sized enterprises (SMEs), and aims to unlock an additional €826 million in private investments. The IPCEI Tech4Cure is expected to create around 800 jobs and will contribute to the updated Industrial Strategy by promoting industrial resilience and reinforcing the Single Market.

Key Takeaways:

  • The IPCEI Tech4Cure involves 10 companies, including 6 SMEs, and is expected to create around 800 jobs.
  • The project aims to unlock an additional €826 million in private investments.
  • The IPCEI Tech4Cure will contribute to the updated Industrial Strategy by promoting industrial resilience and reinforcing the Single Market.
  • The project focuses on the creation of innovative medical devices with advanced and novel digital/AI solutions, including predictive, preventive, and personalised medicine (3P medicine).
  • The 3P medicine concept involves the use of data and analytical tools to predict future health risks, early detection of risk factors and medical conditions, and adapting treatments and care plans to the unique characteristics of each individual patient.
  • The project involves collaboration between 10 companies and over 70 planned collaborations with other partners in the wider IPCEI ecosystem.
  • The Commission has verified that the total planned maximum aid amounts are in line with the eligible costs of the projects and their funding gaps.
  • The results of the project will be widely shared by participating companies with the European scientific community and industry, generating positive spillover effects throughout Europe.
  • The project aims to promote industrial resilience and reinforce the Single Market, encouraging the competitiveness of the EU medical devices industry and supporting the green and digital transitions with advanced, safe, and innovative medical technologies.
  • The Commission has assessed the project under EU State aid rules and concluded that it fulfils the required conditions, including contributing to EU objectives, overcoming market failures, and generating positive spillover effects in the EU.
  • The IPCEI Tech4Cure ecosystem involves 18 associated partners from four Member States and around 45 indirect partners.

Statistics:

  • Total funding for the IPCEI Tech4Cure: €1.23 billion
  • Public funding: up to €403 million
  • Private investments: up to €826 million
  • Number of companies involved: 10
  • Number of SMEs involved: 6
  • Expected jobs created: around 800
  • Planned collaborations: over 70
  • Number of associated partners: 18
  • Number of indirect partners: around 45

Sources:

  • European Commission, "European Commission approves IPCEI Tech4Cure: A €1.23 billion medical devices initiative"
  • European Commission, "Important Projects of Common European Interest (IPCEI)"
  • European Commission, "State Aid Weekly e-News"
  • European Commission, "DG COMP IPCEI website"
  • Contify.com, "European Commission Approves IPCEI Tech4Cure"

Read more